Short answer
Cullinan Therapeutics, Inc. (CGEM) filed an 8-K current report with the SEC on March 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year 2025 financial results announced March 10, 2026.
Cullinan Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Full-year 2025 financial results announced March 10, 2026
- Complete figures in Exhibit 99.1 press release: refer there for revenue, cash, and expense details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cullinan Therapeutics, Inc. 8-K filings
Get the next CGEM 8-K as it lands
Follow CGEM for push alerts, or ask the research agent what this filing means.